Publications

Find at Harvard

15 Dec 2024
News

After Ozempic

Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details

Keywords: Jen McFarland Flint; Illustrations by Pete Ryan; Ambulatory Health Care Services; Health, Social Assistance

2006
Chapter

BioRisk: interleukin-2 from laboratory to market in the United States and Germany

By: Arthur A. Daemmrich

Keywords: Product Development; Risk and Uncertainty; Health Testing and Trials; Pharmaceutical Industry; Biotechnology Industry; United States; Germany

March 2015 (Revised February 2022)
Supplement

CV Ingenuity (B): Epilogue

By: Regina E. Herzlinger and Andrew Otazo

Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors? The... View Details

01 May 2020
News

How Everlywell Pulled Off Its COVID-19 Pivot in Two Weeks

Web

Artist Support | Baker Library

Artist Support Photo: Ansel Adams and Gerry Sharpe, test photograph by Ansel Adams, 1958, © The Ansel Adams Publishing Rights Trust. Polaroid Corporation Corporate Archives Records, b. IX.42, f. 4. Meroë Morse served as Polaroid’s liaison... View Details

04 Sep 2019
News

Advancing Diagnostics that Can Save Lives

Above: photo by Len Rubenstein No disease can be slowed or stopped until it is diagnosed. For diseases with available treatments, the facts are simple: The earlier they are detected, the higher the survival rates. Two companies at the Pagliuca Harvard Life Lab are... View Details

Keywords: Susan Young

June 2023 (Revised July 2024)
Case

Biogen and the Aduhelm Melee

By: Amitabh Chandra and Lauren Gunasti

Alzheimer's Disease is a devastating condition affecting millions of Americans. At this time, there is no cure. In 2021, Biogen's Aduhelm (aducanumab) received FDA approval under the accelerated approval pathway after a controversial approval process.

This... View Details

Keywords: Health Testing and Trials; Governing Rules, Regulations, and Reforms; Valuation; Product Development; Pharmaceutical Industry

August 2023 (Revised May 2024)
Case

Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations

By: Satish Tadikonda and Amanda McEwen

The success or failure of Dicerna Pharmaceuticals (Dicerna) as an emerging pharmaceutical company would likely hinge on its lead drug candidate Nedosiran and the company’s ability to see it successfully through clinical development. Ralf Rosskamp, Chief Medical... View Details

Keywords: Business Strategy; Health Testing and Trials; Product Development; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry

September–October 2020
Article

The Past, Present, and (Near) Future of Gene Therapy and Gene Editing

By: Julia Pian, Amitabh Chandra and Ariel Dora Stern

Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused... View Details

Keywords: Gene Therapy; Gene Editing; Impact; Health Care and Treatment; Technological Innovation; Health Testing and Trials; Venture Capital; Change

Find at Harvard

Read Now

December 2002
Teaching Note

Abgenix and the XenoMouse (TN)

By: John T. Gourville

Teaching Note for (501-061). View Details

Keywords: Health Testing and Trials; Decision Choices and Conditions; Sales; Product Development; Joint Ventures; Health Industry; Pharmaceutical Industry

January 2007
Article

A Randomized Clinical Trial of EMDR, Fluoxetine and Pill Placebo in the Treatment of PTSD: Treatment Effects and Long-term Maintenance

By: Bessel A. van der Kolk, Joseph Spinazzola, Margaret E. Blaustein, James Hopper, Elizabeth Hopper, Deborah Korn and William B. Simpson

Keywords: Health Testing and Trials; Health Care and Treatment; Health Disorders

Find at Harvard

24 Mar 2020
Research & Ideas

These Coronavirus Heroes Show Us How Crisis Leadership Works

Schinecker, CEO of Roche Diagnostics, leads a company that received the FDA’s first emergency use authorization for a commercially developed COVID-19 test on March 13. Roche now believes it can ship up to 400,000 View Details

Keywords: by Bill George; Health

Web

Admissions Resources - Doctoral

letters, and suggestions on how to identify and approach your recommenders. Standardized Tests As you prepare for your PhD application, watch this video to learn more about what standardized tests are... View Details

March 2016
Case

Evive Health and Workplace Influenza Vaccinations

By: John Beshears

Evive Health is a company that manages communication campaigns on behalf of health insurance plans and large employers. Using big data techniques and insights from behavioral economics, Evive deploys targeted and effective messages that improve individuals' health... View Details

Keywords: Vaccination; Influenza; Flu Shot; Preventive Care; Health Care; Behavioral Economics; Choice Architecture; Nudge; Experimental Design; Randomized Controlled Trial; RCT; Causal Inference; Consumer Behavior; Health Care and Treatment; Health Testing and Trials; Communication Strategy; Health Industry

01 Jun 2004
News

Who, Me?

online, specifically to Tickle.com, a social interaction Web site founded and run by James Currier (MBA ’99). “Tickle is an interpersonal media company about everyone’s favorite subject: themselves,” Currier explained to the New York Times (March 8, 2004). The company... View Details

Keywords: Tickle.com; social media; tickle; News, Library, Internet, and Other Services; Information

16 May 2016
HBS Case

Food Safety Economics: The Cost of a Sick Customer

when more than 50 people in 11 states were sickened by an initial E. coli outbreak. “Do those smaller local organic growers have the experience, resources, and commitment to test their products for various food safety risks?” The chain... View Details

Keywords: by Dina Gerdeman; Food & Beverage

23 Aug 2020
News

In the UK, She Leads the Search for a COVID Vaccine

Kate Bingham (MBA 1991) Kate Bingham (MBA 1991) When she was asked to chair the UK’s Vaccine Taskforce back in May, Kate Bingham (MBA 1991) paused. Despite nearly three decades of experience as a life sciences investor with SV Health Investors, the enormity of leading... View Details

Keywords: COVID-19; vaccines; leadership; biomedicine; venture capital; operations; public health; government innovation; Finance; Scientific Research and Development Services

December 2023 (Revised March 2024)
Case

Manufacturing Moderna's Future

By: Satish Tadikonda and William Marks

In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details

Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry